Mirae Asset Global ETFs Holdings
SRPT icon

Mirae Asset Global ETFs Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Buy
73,116
+2,975
+4% +$57.6K ﹤0.01% 1287
2025
Q4 		$1.51M Buy
70,141
+26,933
+62% +$568K ﹤0.01% 1297
2025
Q3 		$829K Buy
43,208
+758
+2% +$13.5K ﹤0.01% 1600
2025
Q2 		$726K Buy
42,450
+13,621
+47% +$581K ﹤0.01% 1606
2025
Q1 		$1.87M Sell
28,829
-1,403
-5% -$148K ﹤0.01% 1178
2024
Q4 		$3.67M Sell
30,232
-814
-3% -$99.8K 0.01% 866
2024
Q3 		$3.88M Sell
31,046
-5,825
-16% -$805K 0.01% 846
2024
Q2 		$5.83M Buy
+36,871
New +$4.74M 0.01% 701

Other funds holding SRPT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return